ZyVersa Therapeutics shares are trading higher after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities...

ZyVersa Therapeutics, Inc. - Common Stock -0.68%

ZyVersa Therapeutics, Inc. - Common Stock

ZVSA

4.35

-0.68%

ZyVersa Therapeutics shares are trading higher after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer's Disease.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via